CFO
Alivus Life Sciences Limited
Equibles does not estimate personal net worth.
Tushar Mistry is recorded as CFO at Alivus Life Sciences Limited. Tushar Mistry has spoken on 3 earnings calls across 1 company, most recently for Alivus Life Sciences Limited on October 30, 2026. Alivus Life Sciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“I would like to take a moment to highlight the key performance updates for the quarter and For Q2 FY27, revenue from operations stood at Rs. 682, a growth of 16% year-on-year.”
“I would like to highlight the key performance updates for the quarter ended 38 June 2026. For Q1 F527, revenue from operations stood at 640 crores, a growth of 6.4% year-on-year.”
“Adding to Dr. Yassir's commentary, I would like to share a few insights on our performance over the last two years, particularly how our growth profile and profitability have meaningfully improved.”
Alivus Life Sciences Limited
CFO
Transcript header (unverified)
Alivus Life Sciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call
Alivus Life Sciences Limited
Earnings Call for the Quarter Ended June 30, 2026
Alivus Life Sciences Limited
Earnings Call for the Quarter Ended March 31, 2026
Alivus Life Sciences Limited
